Terms: = Leukemia AND BCOR, ANOP2, 54880, ENSG00000183337, MAA2, MCOPS2, FLJ38041, KIAA1575, MGC131961, FLJ20285, MGC71031 AND Prognosis
27 results:
1. Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.
Shimony S; Bewersdorf JP; Shallis RM; Liu Y; Schaefer EJ; Zeidan AM; Goldberg AD; Stein EM; Marcucci G; Lindsley RC; Chen EC; Ramos Perez J; Stein A; DeAngelo DJ; Neuberg DS; Stone RM; Ball B; Stahl M
Leukemia; 2024 Apr; 38(4):762-768. PubMed ID: 38378841
[TBL] [Abstract] [Full Text] [Related]
2. Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia.
Han H; Yao Y; Wang H; Zhou M; Zhang Z; Xu X; Qi J; Liu Y; Wu D; Han Y
Cancer; 2023 Jan; 129(2):245-254. PubMed ID: 36370049
[TBL] [Abstract] [Full Text] [Related]
3. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
4. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
[TBL] [Abstract] [Full Text] [Related]
5. B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers.
McLachlan T; Matthews WC; Jackson ER; Staudt DE; Douglas AM; Findlay IJ; Persson ML; Duchatel RJ; Mannan A; Germon ZP; Dun MD
Mol Cancer Res; 2022 Dec; 20(12):1711-1723. PubMed ID: 36166198
[TBL] [Abstract] [Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
Song GY; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Choi SH; Kim MY; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Zhang Z; Ahn JS; Kim HJ; Kim DDH
Bone Marrow Transplant; 2022 Dec; 57(12):1810-1819. PubMed ID: 36151367
[TBL] [Abstract] [Full Text] [Related]
7. Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid leukemia.
Li F; Li N; Wang A; Liu X
Clin Interv Aging; 2022; 17():1187-1197. PubMed ID: 35967966
[TBL] [Abstract] [Full Text] [Related]
8. Dynamics of epigenetic regulator gene bcor mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.
Li X; Xu F; Zhang Z; Guo J; He Q; Song LX; Wu D; Zhou LY; Su JY; Xiao C; Chang CK; Wu LY
Clin Epigenetics; 2021 Aug; 13(1):169. PubMed ID: 34461985
[TBL] [Abstract] [Full Text] [Related]
9. Loss-of-function mutations in bcor contribute to chemotherapy resistance in acute myeloid leukemia.
Honda A; Koya J; Yoshimi A; Miyauchi M; Taoka K; Kataoka K; Arai S; Kurokawa M
Exp Hematol; 2021 Sep; 101-102():42-48.e11. PubMed ID: 34333045
[TBL] [Abstract] [Full Text] [Related]
10. Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
Kanagal-Shamanna R; Montalban-Bravo G; Sasaki K; Darbaniyan F; Jabbour E; Bueso-Ramos C; Wei Y; Chien K; Kadia T; Ravandi F; Borthakur G; Soltysiak KA; Routbort M; Patel K; Pierce S; Medeiros LJ; Kantarjian HM; Garcia-Manero G
Cancer; 2021 Oct; 127(19):3552-3565. PubMed ID: 34161603
[TBL] [Abstract] [Full Text] [Related]
11. Features and impacts on the prognosis of gene mutations in patients with acute myeloid leukemia.
Wu M; Guo ZW; Huang GN; Ye YB
Neoplasma; 2021 Sep; 68(5):1072-1078. PubMed ID: 33998238
[TBL] [Abstract] [Full Text] [Related]
12. [The Relationship between ASXL2 and ZBTB7A Gene Mutations and prognosis in Patients with Acute Myeloid leukemia].
Cao HQ; Tuo JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):450-455. PubMed ID: 33812414
[TBL] [Abstract] [Full Text] [Related]
13. Modeling and targeting of erythroleukemia by hematopoietic genome editing.
Iacobucci I; Qu C; Varotto E; Janke LJ; Yang X; Seth A; Shelat A; Friske JD; Fukano R; Yu J; Freeman BB; Kennedy JA; Sperling AS; Zheng R; Wang Y; Jogiraju H; Dickerson KM; Payne-Turner D; Morris SM; Hollis ES; Ghosn N; Haggard GE; Lindsley RC; Ebert BL; Mullighan CG
Blood; 2021 Mar; 137(12):1628-1640. PubMed ID: 33512458
[TBL] [Abstract] [Full Text] [Related]
14. Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies.
Kaito S; Iwama A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374737
[TBL] [Abstract] [Full Text] [Related]
15. Additional gene mutations may refine the 2017 European leukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
Eisfeld AK; Kohlschmidt J; Mims A; Nicolet D; Walker CJ; Blachly JS; Carroll AJ; Papaioannou D; Kolitz JE; Powell BE; Stone RM; de la Chapelle A; Byrd JC; Mrózek K; Bloomfield CD
Leukemia; 2020 Dec; 34(12):3215-3227. PubMed ID: 32461631
[TBL] [Abstract] [Full Text] [Related]
16. Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
Simonetti G; Padella A; do Valle IF; Fontana MC; Fonzi E; Bruno S; Baldazzi C; Guadagnuolo V; Manfrini M; Ferrari A; Paolini S; Papayannidis C; Marconi G; Franchini E; Zuffa E; Laginestra MA; Zanotti F; Astolfi A; Iacobucci I; Bernardi S; Sazzini M; Ficarra E; Hernandez JM; Vandenberghe P; Cools J; Bullinger L; Ottaviani E; Testoni N; Cavo M; Haferlach T; Castellani G; Remondini D; Martinelli G
Cancer; 2019 Mar; 125(5):712-725. PubMed ID: 30480765
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative diagnosis of clear cell sarcoma of the kidney by detection of bcor internal tandem duplication in circulating tumor DNA.
Ueno-Yokohata H; Okita H; Nakasato K; Hishiki T; Shirai R; Tsujimoto S; Osumi T; Yoshimura S; Yamada Y; Shioda Y; Kiyotani C; Terashima K; Miyazaki O; Matsumoto K; Kiyokawa N; Yoshioka T; Kato M
Genes Chromosomes Cancer; 2018 Oct; 57(10):525-529. PubMed ID: 30126017
[TBL] [Abstract] [Full Text] [Related]
18. Usefulness of bcor gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
[TBL] [Abstract] [Full Text] [Related]
19. [Relationship between clinical features and somatic gene mutations in myelodysplastic syndrome].
Hirasawa N; Sakata-Yanagimoto M; Nannya Y; Hattori K; Suehara Y; Kato T; Yokoyama Y; Kurita N; Obara N; Ogawa S; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2018; 59(1):80-83. PubMed ID: 29415943
[TBL] [Abstract] [Full Text] [Related]
20. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract] [Full Text] [Related]
[Next]
